4qpf
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption== | ==New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption== | ||
<StructureSection load='4qpf' size='340' side='right' caption='[[4qpf]], [[Resolution|resolution]] 1.59Å' scene=''> | <StructureSection load='4qpf' size='340' side='right' caption='[[4qpf]], [[Resolution|resolution]] 1.59Å' scene=''> | ||
| Line 5: | Line 6: | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=39L:[1-FLUORO-2-(IMIDAZO[1,2-A]PYRIDIN-3-YL)ETHANE-1,1-DIYL]BIS(PHOSPHONIC+ACID)'>39L</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=39L:[1-FLUORO-2-(IMIDAZO[1,2-A]PYRIDIN-3-YL)ETHANE-1,1-DIYL]BIS(PHOSPHONIC+ACID)'>39L</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1zw5|1zw5]], [[1yq7|1yq7]], [[2vf6|2vf6]], [[3b7l|3b7l]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1zw5|1zw5]], [[1yq7|1yq7]], [[2vf6|2vf6]], [[3b7l|3b7l]]</td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qpf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qpf OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4qpf RCSB], [http://www.ebi.ac.uk/pdbsum/4qpf PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qpf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qpf OCA], [http://pdbe.org/4qpf PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4qpf RCSB], [http://www.ebi.ac.uk/pdbsum/4qpf PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4qpf ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
Revision as of 14:26, 29 March 2017
New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption
| |||||||||||
Categories: Barnett, B L | Duan, Z | Dunford, J E | Ebetino, F H | Jeans, G | Kwaasi, A A | Lundy, M | Mazur, A | Russell, R G.G | Triffitt, J | All-alpha helical prenyltransferase | Bisphosphonate | Cholesterol synthesis | Dimethylallyl pyrophosphate | Isopentyl pyrophosphate | Isoprene biosynthesis | Isoprenoid pathway | Lipid synthesis | Steroid biosynthesis | Transferase
